Published • loading... • Updated
A revolutionary cancer treatment could transform autoimmune disease
- Jan Janisch-Hanzlik, age 49, had multiple sclerosis that severely limited her lifestyle freedom.
- CAR T therapy, initially developed for cancer by reprogramming immune cells, is now in clinical trials for autoimmune diseases such as multiple sclerosis and lupus.
- This treatment aims to eliminate harmful cells that attack the body in autoimmune diseases, mirroring its success in blood cancers.
- A German team reported positive results using CAR T therapy on a woman with lupus in 2021, highlighting the role of B cells in autoimmune problems despite the treatment's complexity.
Insights by Ground AI
20 Articles
20 Articles
A revolutionary cancer treatment could transform autoimmune disease - Hillsboro Sentry Enterprise
A revolutionary cancer treatment could transform autoimmune diseaseAt age 49, Jan Janisch-Hanzlik’s multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her active nursing job for a desk role. Frequent falls made her afraid to carry her grandchildren. She had to move to a bigger house to make room for the wheelchair she feared she might end up needing full-time.Even the best available medication wasn’t improving…
·Hillsboro, United States
Read Full ArticleCoverage Details
Total News Sources20
Leaning Left1Leaning Right4Center9Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
C 64%
R 29%
Factuality
To view factuality data please Upgrade to Premium
